Simplex Trading
BMY icon

Simplex Trading’s Bristol-Myers Squibb BMY Stock Holding History

Simplex Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.1M Sell
414,400
-491,200
-54% -$28.6M 0.02% 365
2025
Q4 		$48.8M Sell
905,600
-649,600
-42% -$31.3M 0.03% 298
2025
Q3 		$70.1M Buy
1,555,200
+46,800
+3% +$2.19M 0.04% 267
2025
Q2 		$69.8M Buy
1,508,400
+406,600
+37% +$20M 0.04% 222
2025
Q1 		$67.2M Buy
1,101,800
+219,900
+25% +$12.8M 0.04% 200
2024
Q4 		$49.9M Sell
881,900
-800,400
-48% -$44.7M 0.03% 306
2024
Q3 		$87M Buy
1,682,300
+51,000
+3% +$2.39M 0.05% 191
2024
Q2 		$67.7M Buy
1,631,300
+507,100
+45% +$22.7M 0.04% 237
2024
Q1 		$61M Buy
1,124,200
+246,900
+28% +$12.6M 0.04% 292
2023
Q4 		$45M Sell
877,300
-51,600
-6% -$2.71M 0.03% 383
2023
Q3 		$53.9M Buy
928,900
+228,000
+33% +$14M 0.04% 272
2023
Q2 		$44.8M Sell
700,900
-36,600
-5% -$2.45M 0.04% 295
2023
Q1 		$51.1M Sell
737,500
-406,200
-36% -$28.6M 0.04% 274
2022
Q4 		$82.3M Sell
1,143,700
-179,900
-14% -$13.6M 0.09% 178
2022
Q3 		$94.1M Buy
1,323,600
+99,900
+8% +$7.25M 0.11% 127
2022
Q2 		$94.2M Buy
1,223,700
+443,900
+57% +$33.8M 0.1% 127
2022
Q1 		$56.9M Sell
779,800
-209,100
-21% -$14M 0.05% 259
2021
Q4 		$61.7M Buy
988,900
+624,400
+171% +$36.6M 0.06% 237
2021
Q3 		$24.3M Buy
364,500
+5,700
+2% +$375K 0.02% 403
2021
Q2 		$24M Buy
358,800
+353,319
+6,446% +$23M 0.02% 397
2021
Q1 		$34.6M Sell
5,481
-801
-13% -$49.8K 0.06% 182
2020
Q4 		$39M Sell
6,282
-2,017
-24% -$124K 0.05% 212
2020
Q3 		$49.4M Sell
8,299
-1,698
-17% -$102K 0.07% 163
2020
Q2 		$58.2M Sell
9,997
-457
-4% -$27.3K 0.09% 127
2020
Q1 		$56.3M Buy
10,454
+1,167
+13% +$71.3K 0.1% 100
2019
Q4 		$4.44M Buy
9,287
+3,435
+59% +$197K 0.01% 876
2019
Q3 		$29.7M Sell
5,852
-460
-7% -$21.6K 0.08% 166
2019
Q2 		$28.6M Sell
6,312
-8,277
-57% -$386K 0.08% 159
2019
Q1 		$69.6M Buy
14,589
+11,694
+404% +$583K 0.19% 60
2018
Q4 		$15M Buy
2,895
+436
+18% +$23.4K 0.04% 258
2018
Q3 		$15.3M Buy
2,459
+131
+6% +$7.77K 0.05% 249
2018
Q2 		$12.9M Sell
2,328
-926
-28% -$50K 0.05% 279
2018
Q1 		$341K Buy
3,254
+130
+4% +$8.36K 0.02% 913
2017
Q4 		$533K Sell
3,124
-494
-14% -$30.9K 0.02% 683
2017
Q3 		$410K Sell
3,618
-2,081
-37% -$122K 0.02% 771
2017
Q2 		$1.26M Buy
5,699
+525
+10% +$28.6K 0.05% 288
2017
Q1 		$1.2M Buy
5,174
+1,876
+57% +$103K 0.05% 327
2016
Q4 		$552K Sell
3,298
-1,571
-32% -$85.9K 0.03% 498
2016
Q3 		$1.48M Buy
4,869
+3,277
+206% +$211K 0.1% 183
2016
Q2 		$311K Buy
1,592
+611
+62% +$43.2K 0.02% 753
2016
Q1 		$239K Sell
981
-3,232
-77% -$204K 0.02% 772
2015
Q4 		$130K Buy
4,213
+1,450
+52% +$95.8K 0.01% 1154
2015
Q3 		$747K Buy
2,763
+2,036
+280% +$129K 0.05% 311
2015
Q2 		$104K Sell
727
-503
-41% -$33.1K 0.01% 1184
2015
Q1 		$240K Sell
1,230
-517
-30% -$32.4K 0.03% 639
2014
Q4 		$191K Buy
+1,747
New +$98.5K 0.02% 624

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's BMY Position: Q4 2025 in Review

Simplex Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 256,777 shares — an estimated $12.4M sold.

Simplex Trading first reported a position in BMY in Q1 2015 and held it in 33 quarters. The position peaked at $27.3M in Q1 2024. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Simplex Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 256,777 Bristol-Myers Squibb shares in Q4 2025, an estimated $12.4M.
  • Simplex Trading first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 33 quarters.
  • Simplex Trading's Bristol-Myers Squibb position peaked at $27.3M in Q1 2024.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.